Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Toxicologic Pathology
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Diwan, B.A.
Right arrow Articles by Buzard, G.S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Diwan, B.A.
Right arrow Articles by Buzard, G.S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Renal Pathology in Hemizygous Sickle Cell Mice

B.A. Diwan

IRSP, SAIC Frederick, NCI at Frederick, Frederick, Maryland, bdiwan{at}mail.ncifcrf.gov

M.T. Gladwin

Critical Care Medicine Department, National Institutes of Health, Bethesda, Maryland

C.T. Noguchi

Laboratory of Chemical Biology, NIDDK, National Institutes of Health, Bethesda, Maryland

J.M. Ward

Veterinary and Tumor Pathology Section, NCI at Frederick, Frederick, Maryland

A.L. Fitzhugh

IRSP, SAIC Frederick, NCI at Frederick, Frederick, Maryland

G.S. Buzard

IRSP, SAIC Frederick, NCI at Frederick, Frederick, Maryland

Transgenic mice have been developed that express exclusively human sickle cell βhemoglobin and have major pathological features found in humans with sickle cell disease. These mice provide a unique opportunity to investigate the fundamental mechanisms of this disease and to design new strategies to correct the associated genetic defect(s). We found that in breeding males expressing only adult human {alpha}-globin and sickle β-globin (homozygous SS mice) with females containing these transgenes plus one copy of the mouse β-globin gene (hemizygous SS mice) greater than expected numbers of hemizygous offspring were produced than homozygous mice (carrying no mouse β-globin gene). These hemizygous mice, expressing the human {alpha} and sickle βs transgenes in combination with mouse β +/-, were used for our preliminary studies of their renal pathology. No kidney lesions were found in the control (129/Sv) mice, whereas about 50% of the hemizygous SS mice showed mild-to-severe kidney lesions, including glomerulonephritis, cystic atypical hyperplastic tubules, and general nephropathy. Kidneys of some hemizygous mice were normal or showed minimal nephropathy, yet those of the susceptible phenotype developed a mild-to-more-severe form of renal lesions. The tubular epithelium of kidneys of hemizygous mice of the more affected phenotype exhibited increased expression of inducible nitric oxide synthase with an increased 3-nitrotyrosine in close proximity. There was also a stronger immunostaining for vascular cell adhesion molecule-1 in the interstitial capillary cells as well as the tubular epithelial cells of the renal cortex, compared with normal control mice. The occurrence of a high incidence of renal abnormalities in our hemizygous SS mice suggests that these mice may provide a suitable model to study the pathogenesis of nephropathy resulting from altered blood fl ow and/or insuffi cient oxygen delivery.

Key Words: Sickle cell disease • sickle cell trait • mouse • homozygous • hemizygous • kidney • pathology • immunohistochemistry.

References

  • Andersen GN, Caidahl K., Kazzam E., Petersson A-S., Waldenström A., Mincheva-Nilsson L., Rantapää-Dahlqvist S. (2000). Correlation between increased nitric oxide production and markers of endothelial activation in systemic sclerosis: Findings with the soluble adhesion molecules E-selectin, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1. Arthritis Rheum 43: 1085—1093.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Andersson KE, Wagner G. (1995). Physiology of penile erection. Physiol Rev 75: 191—236.[Free Full Text]
  • Ataga AK, Orringer EP (2000). Renal abnormalities in sickle cell disease. Am J Hematol 63: 205—211.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Bank N., Aynedjian HS, Qui J-H., Osei SY, Ahima RS, Fabry ME, Nagel RL (1996). Renal nitric oxide synthases in transgenic sickle cell mice. Kidney Int 50: 184—189.[Web of Science][Medline] [Order article via Infotrieve]
  • Bank N., Kiroycheva M., Ahmed F., Anthony GM, Fabry ME, Nagel RL, Singhal PC (1998). Peroxynitrite formation and apoptosis in transgenic sickle cell mouse kidneys. Kidney Int 54: 1520—1528.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Bank N., Kiroycheva M., Singhal PC, Anthony GM, Southan GJ, Szabo C. (2000). Inhibition of nitric oxide synthase ameliorates cellular injury in sickle cell mouse kidneys. Kidney Int 58: 82—89.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Bunn FF (1997). Pathogenesis and treatment of sickle cell disease. N Engl J Med 337: 762—769.[Free Full Text]
  • De Caterina R., Libby P., Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA Jr (1995 ). Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinfl ammatory cytokines. J Clin Invest 96: 60—68.[Web of Science][Medline] [Order article via Infotrieve]
  • Duits AJ, Pieters RC, Saleh AW, van Rosmalen E., Katerberg H., Berend K., Rojer RA (1996). Enhanced levels of soluble VCAM-1 in sickle cell patients and their specifi c increment during vasocclusive crisis. Clin Immunol Immunopathol 81: 96—98.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Fabry ME, Costantini F., Pachnis A., Suzuka SM, Bank N., Aynedjian HS, Factor SM, Nagel RL (1992). High expression of human βs - and {alpha}-globins in transgenic mice: Erythrocyte abnormalities, organ damage, and the effect of hypoxia. Proc Natl Acad Sci USA 89: 12155—12159.[Abstract/Free Full Text]
  • Fowler JEJr, Koshy M., Strub M., Chinn SK (1991). Priapism associated with the sickle cell hemoglobinopathies: Prevalence, natural history and sequelae. J Urol 145: 65—68.[Web of Science][Medline] [Order article via Infotrieve]
  • Gupta AK, Kirchner KA, Nicholson R., Adams AG, Schchter AN, Noguchi CT, Steinburg MH (1991). Effects of {alpha}-thalassemia and sickle polymerization tendency on urine-concentrating defect of individuals with sickle cell trait. J Clin Invest 88: 1963—1968.[Web of Science][Medline] [Order article via Infotrieve]
  • Hammerman SI, Klings ES, Hendra KP, Upchurch GR, Rishikof DC, Loscalzo J., Farber HW (1999). Endothelial cell nitric oxide production in acute chest syndrome. Am J Physiol 277: 1579—1592.
  • Hard GC (1986). Experimental models for the sequential analysis of chemically-induced renal carcinogenesis. Toxicol Pathol 14: 112— 122.
  • Johnson CS, Giorgio AJ (1981). Arterial blood pressurein adults with sickle cell disease. Arch Intern Med 141: 891—893.[Abstract/Free Full Text]
  • Kawachi S., Cockrell A., Laroux FS, Gray L., Granger DN, van der Heyde HC, Grisham MB (1999). Role of inducible nitric oxide synthase in the regulation of VCAM-1 expression in gut infl ammation. Am J Physiol 277: G572—576.[Web of Science][Medline] [Order article via Infotrieve]
  • Khan BV, Harrison DG, Olbrych MT, Alexander RW, Medford RM (1996). Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Proc Natl Acad Sci USA 93: 9114—9119.[Abstract/Free Full Text]
  • Lopez BL, Davis-Moon L., Ballas SK, Ma XL (2000). Sequential nitric oxide measurement s during the emergency department treatment of acute vasocclusive sickle cell crisis. Am J Hematol 64: 15—19.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Monplaisir N., Merault G., Poyart C., Rhoda MD, Craescu C., Vidaud M., Galacteros F., Blouquit Y., Rosa J. (1986). Hemoglobin S Antilles: A variant with lower solubility than hemoglobin S and producing sickle cell disease in heterozygotes. Proc Natl Acad Sci USA 83: 9363— 9367.
  • Morris CR, Kuypers FA, Larkin S., Vichinsky EP, Styles LA (2000). Patterns of arginine and nitric oxide in patients with sickle cell disease with vasoocclusive crisis and acute chest syndrome. J Pediatr Hematol Oncol 22: 515—520.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Osei SY, Ahima RS, Fabry ME, Nagel RL, Bank N. ( 1996). Immunohistochemical localization of hepatic nitric oxide synthase in normal and transgenic sickle cell mice: The effect of hypoxia. Blood 88: 3583— 3588.[Web of Science]
  • Pászty C., Brion CM, Manci E., Witkowska HE, Stevens ME, Mohandas N., Rubin EM (1997). Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease. Science 278: 876— 878.[Free Full Text]
  • Peng H-B., Spiecker M., Liao JK ( 1998). Inducible nitric oxide: An autoregulatory feedback inhibitor of vascular inflammation. J Immunol 161: 1970—1976.[Abstract/Free Full Text]
  • Pham P-T T, Pham P-C T., Wilkinson AH, Lew SQ (2000). Renal abnormalities in sickle disease. Kidney Int 57: 1—8.[Web of Science][Medline] [Order article via Infotrieve]
  • Platt RS, Brambilla DJ, Rosse WF, Milner PF, Castro O., Steinberg MH, Klug PP ( 1994). Mortality in sickle cell disease: Life expectancy and risk factors for early death. N Engl J Med 330: 1639—1644.[Abstract/Free Full Text]
  • Rees DC, Cervi P., Grimwade D., Ódriscoll A., Hamilton M., Parker NE, Porter JB (1995). The metabolites of nitric oxide in sickle-cell disease. Brit J Hematol 91: 834—837.[Web of Science][Medline] [Order article via Infotrieve]
  • Ryan TM, Ciavatta DJ, Townes TM (1997). Knockout-transgeni c mouse model of sickle cell disease. Science 278: 873—876.[Abstract/Free Full Text]
  • Saborio P., Scheinman JI (1999). Sickle cell nephropathy. J Am Soc Nephrol 10: 187—192.[Free Full Text]
  • Sesso R., Almeida MA, Figueiredo MS, Bordin JO (1998). Renal dysfunction in patients with sickle cell anemia or sickle cell trait. Braz J Med Biol Res 31: 1257—1262.[Web of Science][Medline] [Order article via Infotrieve]
  • Setty BN, Stuart MJ (1996). Vascular cell adhesion molecule- 1 is involved in mediating hypoxia-induced sickle red blood cell adherence to endothelium: Potential role in sickle cell disease. Blood 88: 2311—2320.[Abstract/Free Full Text]
  • Space SL, Lane PA, Pickett CK, Weil JV ( 2000). Nitric oxide attenuates normal and sickle red blood cell adherence to pulmonary endothelium. Am J Hematol 63: 200—204.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Spiecker M., Peng HB, Liao JK (1997). Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of I{kappa}B{alpha}. J Biol Chem 272: 30969— 30974.[Abstract/Free Full Text]
  • Stuart MJ, Setty BNY (1999). Sickle cell acute chest syndrome: Pathogenesis and rationale for treatment. Blood 94: 1555—1560.[Abstract/Free Full Text]
  • Takahashi M., Ikeda U., Masuyama JI, Funayama H., Kano S., Shimada K. (1996). Nitric oxide attenuates adhesion molecule expression in human endothelial cells. Cytokine 8: 817—821.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Wesche WA, Wilimas J., Khare V., Parham DM (1998). Renal medullary carcinoma: A potential sickle cell nephropathy of children and adolescents. Pediatr Pathol Lab Med 18: 97—113.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Zadeiig G., Lohr JW ( 1997). Renal papillary necrosis in a patient with sickle cell trait. J Am Soc Nephrol 8: 1034—1039.[Abstract]

Toxicologic Pathology, Vol. 30, No. 2, 254-262 (2002)
DOI: 10.1080/019262302753559597
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Diwan, B.A.
Right arrow Articles by Buzard, G.S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Diwan, B.A.
Right arrow Articles by Buzard, G.S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?